What Should an Importer Do If the Medical Device Model Is Missing from the Approved Product List

Importing medical devices into India requires strict Medical device import compliance with the Medical Devices Rules (MDR), 2017, and Central Drugs Standard Control Organization (CDSCO) requirements. A common issue arises when an Approved product list missing model situation occurs—meaning a specific model of an otherwise approved device does not appear on the list attached to the import licence. Shipping or clearing such a model without proper inclusion can trigger customs action or regulatory non-compliance.

Understanding the Approved Product List Under MDR 2017

Under the Medical Devices Rules, 2017, an import licence is granted in Form MD-15 after an application in Form MD-14. The licence is linked to a specific manufacturing site and lists the approved devices along with their generic names, brand names (if any), model numbers, intended use, and other technical particulars drawn from the Device Master File.

Only the models explicitly listed are authorised for commercial import and sale. If a new or additional model of the same device family is missing, it is not covered. Attempting an Unlisted medical device model import without updating the licence violates the rules and can lead to Medical device import restrictions.

CDSCO has clarified the correct route in its official FAQ (Addendum to FAQ on Medical Devices Rules, 2017). When the model name or number to be added is consistent with the risk class, intended use, and technical characteristics already described in the current Device Master File, the licence holder must submit a post-approval change application rather than a completely new import licence application. This process serves as the practical CDSCO import license amendment pathway.

Why the Model Must Appear on the Approved List

The approved product list ensures traceability, safety, and performance accountability. Customs authorities and CDSCO verify that the physical goods match the licensed models. A mismatch can result in the consignment being held—creating an urgent need for a Medical device customs hold solution—or returned, or subjected to penalties under the Drugs and Cosmetics Act, 1940, and MDR 2017.

For systems licensed under grouping guidelines, adding models may also require a change from “System” grouping to “Family” grouping so that additional models can be properly included. Deleting or modifying an existing model number similarly requires a post-approval change application. Performing a proper Medical device market authorization check before shipment helps avoid these problems.

Step-by-Step Actions for the Importer or Authorised Agent

1. Verify the Existing Licence and Device Master File
   Log into the CDSCO Online System for Medical Devices (cdscomdonline.gov.in). Download the current Form MD-15 and confirm which models are listed. Cross-check the Device Master File to ensure the missing model shares the same risk class, intended use, materials, design characteristics, and performance claims. This is the first step in any reliable Missing device variant import protocol.
2. Confirm Eligibility for Post-Approval Change
   The model must be “in consonance” with the already approved device. If the new model introduces a different intended use, higher risk class, major design change, or new technology, it may be treated as a new device requiring a fresh application (possibly under Form MD-26 if no predicate exists). In most cases of similar models within the same family, the post-approval route applies and allows you to successfully Add model to medical device license.
3. Prepare the Post-Approval Change Application
   Submit the application through the dedicated post-approval change module on the CDSCO medical devices portal. Supporting documents typically include:
   • Covering letter explaining the addition and confirming no impact on safety or performance
   • Updated Device Master File sections showing the new model
   • Comparison table of existing versus proposed models
   • Updated Free Sale Certificate or equivalent from the country of origin listing the additional model (if available)
   • Revised labels and Instructions for Use reflecting the new model
   • Undertaking that quality, safety, and performance remain unchanged
   • Any grouping change request if moving from System to Family

This structured approach provides an effective Regulatory fix unlisted product model.

1. Pay Applicable Fees and Respond to Queries
   Fees depend on the nature of the change and device class. Respond promptly to any deficiency letters issued by CDSCO. Timelines for processing post-approval changes are generally shorter than those for a new licence, but they still require complete and accurate documentation. Delays at this stage are a frequent cause of Import clearance medical device delay.
2. Obtain Endorsement and Update Records
   Once approved, the licence is endorsed with the additional model number(s). Update all internal records, labelling, and shipping documents. Ensure future invoices, packing lists, and Bills of Entry exactly match the models now appearing on the endorsed MD-15. Completing this step keeps your CDSCO medical device registration update fully current.
3. Subsequent Importers
   If you are a subsequent importer of a device already licensed to another agent for the same manufacturing site, you must still obtain your own import licence. Once you hold the licence, the same post-approval change process applies for any missing models.

Practical Tips to Avoid Delays

• Always list all intended models comprehensively at the time of the original MD-14 application.
• Keep the Free Sale Certificate, ISO 13485 certificate, and technical documentation aligned across every model.
• For Class C and Class D devices, extra care is needed because clinical evaluation data must support the entire family.
• Never attempt to clear a non-listed model on the basis of a similar approved model; the licence must explicitly cover it.
• Maintain a robust Quality Management System so that any future model additions can be justified quickly.
• Strong Regulatory compliance for medical importers begins with proactive model verification.

How MDR Consultants Supports Importers Through This Process

Navigating the post-approval change portal, preparing comparison tables, aligning Free Sale Certificates, and responding to CDSCO queries requires specialised knowledge. MDR Consultants provides expert Medical device regulatory consulting for import licences, subsequent importer applications, and post-approval changes under MDR 2017.

Our team reviews your existing Device Master File, confirms eligibility for the addition route, prepares the complete dossier, submits the application on the CDSCO portal, and follows up until the endorsement is granted. We also advise on grouping strategies, labelling compliance, and subsequent importer pathways so that your supply chain remains uninterrupted.

Why Choose MDR Consultants for Your CDSCO Compliance Needs

Importers choose MDR Consultants because we combine deep knowledge of CDSCO guidelines and MDR 2017 with practical, results-oriented support. We understand the exact documentation standards expected by reviewers, the common reasons for queries on model additions, and the timelines that matter to commercial operations. Whether you need a single model endorsement or a full portfolio review of approved product lists, our focused approach helps minimise delays and regulatory risk while keeping your devices moving into the Indian market.

Conclusion

When a medical device model is missing from the approved product list on an MD-15 import licence, the correct and only compliant action is to submit a post-approval change application through the CDSCO Online System for Medical Devices, provided the model remains consistent with the existing risk class, intended use, and technical characteristics. Attempting to import without this update exposes the importer to customs holds, possible seizure, and regulatory non-compliance under MDR 2017.

By following the official CDSCO pathway—verification, documentation, portal submission, and endorsement—importers can lawfully expand their product range. Partnering with experienced regulatory specialists such as MDR Consultants further ensures that the process is handled accurately, efficiently, and in full alignment with current guidelines. Staying proactive on model listings protects both patient safety and business continuity in India’s regulated medical device market.

Last Updated : 18 Sep 2026